Research in the field of immunological and cholestatic liver diseases deals with the establishment of new therapies, especially in the field of primary sclerosing cholangitis in the sense of management and participation in clinical trials.
In addition, the pathogenesis and the clinical course of immunological liver diseases are investigated in the working group in the sense of international collaborations.